143 related articles for article (PubMed ID: 8496627)
41. Serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) are elevated in advanced stages of non-Hodgkin's lymphomas.
Christiansen I; Sundström C; Kälkner KM; Bring J; Tötterman TH
Eur J Haematol; 1999 Mar; 62(3):202-9. PubMed ID: 10089899
[TBL] [Abstract][Full Text] [Related]
42. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma.
Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM
Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841
[TBL] [Abstract][Full Text] [Related]
43. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
[TBL] [Abstract][Full Text] [Related]
44. [Clinical significance of soluble interleukin-2 receptor in multiple myeloma].
Akimoto Y; Ishiyama T; Ueno H; Hino K; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1995 Nov; 36(11):1247-51. PubMed ID: 8691563
[TBL] [Abstract][Full Text] [Related]
45. Clinical significance of sIL-2R levels in B-cell lymphomas.
Yoshida N; Oda M; Kuroda Y; Katayama Y; Okikawa Y; Masunari T; Fujiwara M; Nishisaka T; Sasaki N; Sadahira Y; Mihara K; Asaoku H; Matsui H; Seto M; Kimura A; Arihiro K; Sakai A
PLoS One; 2013; 8(11):e78730. PubMed ID: 24236041
[TBL] [Abstract][Full Text] [Related]
46. Serum levels of CD8 antigen and soluble interleukin 2 receptors in patients with B cell chronic lymphocytic leukemia.
Musolino C; Di Cesare E; Alonci A; Allegra A; Orlando A; Grosso P; Squadrito G
Acta Haematol; 1991; 85(2):57-61. PubMed ID: 1902614
[TBL] [Abstract][Full Text] [Related]
47. Serum levels of interleukin-2 receptor (CD 25) in patients with Hodgkin's disease, with special reference to age and prognosis.
Enblad G; Sundström C; Gronowitz S; Glimelius B
Ann Oncol; 1995 Jan; 6(1):65-70. PubMed ID: 7710984
[TBL] [Abstract][Full Text] [Related]
48. Prognostic parameters in low-grade non-Hodgkin's lymphomas.
Zemunik T; Vucković J; Forenpoher G; Knezević N; Stula N; Dubravcić M; Ribicić I; Rozga A
Neoplasma; 1997; 44(1):13-7. PubMed ID: 9201275
[TBL] [Abstract][Full Text] [Related]
49. Serum level of soluble interleukin-2 receptor correlates with CD25 expression in patients with T lymphoblastic lymphoma.
Toji T; Takata K; Sato Y; Miyata-Takata T; Hayashi E; Habara T; Maeda Y; Tanimoto M; Yoshino T
J Clin Pathol; 2015 Aug; 68(8):622-7. PubMed ID: 25935549
[TBL] [Abstract][Full Text] [Related]
50. Epiregulin: A new prognostic molecule in non-Hodgkin lymphoma.
Demir I; Akan OY; Bilgir F; Yilmaz I; Bozkaya G; Bilgir O
Ir J Med Sci; 2024 Jun; 193(3):1201-1207. PubMed ID: 38270775
[TBL] [Abstract][Full Text] [Related]
51. High cytokine expression and reduced ovarian reserve in patients with Hodgkin lymphoma or non-Hodgkin lymphoma.
Paradisi R; Vicenti R; Macciocca M; Seracchioli R; Rossi S; Fabbri R
Fertil Steril; 2016 Oct; 106(5):1176-1182. PubMed ID: 27430206
[TBL] [Abstract][Full Text] [Related]
52. Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.
Vonderheid EC; Zhang Q; Lessin SR; Polansky M; Abrams JT; Bigler RD; Wasik MA
J Am Acad Dermatol; 1998 Feb; 38(2 Pt 1):207-20. PubMed ID: 9486676
[TBL] [Abstract][Full Text] [Related]
53. Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.
Goto N; Tsurumi H; Goto H; Shimomura YI; Kasahara S; Hara T; Yasuda I; Shimizu M; Murakami N; Yoshikawa T; Fukuno K; Takahashi T; Kito Y; Takami T; Moriwaki H
Ann Hematol; 2012 May; 91(5):705-714. PubMed ID: 22183251
[TBL] [Abstract][Full Text] [Related]
54. [Interleukin-6 (IL-6), soluble interleukin-2-receptor (sIL-2R) and microheterogeneity of alpha-! acid glycoprotein (AGP): new markers of the acute-phase reaction?].
Karrer U; Aeschlimann A; Fassbender K; Vogt P; Müller W
Schweiz Med Wochenschr; 1992 Feb; 122(7):233-6. PubMed ID: 1539125
[TBL] [Abstract][Full Text] [Related]
55. Aggressive non-Hodgkin's lymphoma: concomitant evaluation of interleukin-2, soluble interleukin-2 receptor, interleukin-4, interleukin-6, interleukin-10 and correlation with outcome.
Fabre-Guillevin E; Tabrizi R; Coulon V; Monnereau A; Eghbali H; Soubeyran I; Soubeyran P
Leuk Lymphoma; 2006 Apr; 47(4):603-11. PubMed ID: 16690518
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of serum CD44 measurement in malignant lymphoma.
Fukuda Y
Kurume Med J; 2001; 48(1):65-9. PubMed ID: 11402623
[TBL] [Abstract][Full Text] [Related]
57. Clinical implications of cytokine and soluble receptor measurements in patients with newly-diagnosed aggressive non-Hodgkin's lymphoma.
Stasi R; Zinzani L; Galieni P; Lauta VM; Damasio E; Dispensa E; Dammacco F; Venditti A; Del Poeta G; Cantonetti M
Eur J Haematol; 1995 Jan; 54(1):9-17. PubMed ID: 7859883
[TBL] [Abstract][Full Text] [Related]
58. [Significance of soluble interleukin-2 receptor alpha chain in the management of patients with malignant lymphoma: a multi-center study].
Ohno H; Ishikawa T; Kitajima H; Nomura S; Suzuki T; Konishi H; Ohno Y; Onishi R; Konaka Y; Arima N; Doi S; Nasu K; Takahashi T; Tsudo M; Fukuhara S; Uchiyama T
Rinsho Ketsueki; 2002 Mar; 43(3):170-5. PubMed ID: 11979748
[TBL] [Abstract][Full Text] [Related]
59. The significance of soluble interleukin-2, soluble interleukin-2 receptors, soluble ICAM-1 and beta 2-microglobulin in breast cancer patients.
Klein B; Levin I; Kfir B; Mishaeli M; Shapira J; Klein T
Tumour Biol; 1995; 16(5):290-6. PubMed ID: 7652467
[TBL] [Abstract][Full Text] [Related]
60. Prognostic value of serum beta-2 microglobulin in low-grade lymphoma.
Litam P; Swan F; Cabanillas F; Tucker SL; McLaughlin P; Hagemeister FB; Rodriguez MA; Velasquez WS
Ann Intern Med; 1991 May; 114(10):855-60. PubMed ID: 2014946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
